Alterations of the Serum and CSF Ferritin Levels and the Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis

Overview

Journal eNeurologicalSci

Specialty Neurology

Date 2021 Dec 6

PMID 34869924

Citations 7

Authors

Parastou Paydarnia

Mahsa Mayeli

Mahan Shafie

Elmira Agah

Seyede Anis Hasani

Maryam Rashidi Jazani

Payam Sarraf

Affiliations

Soon will be listed here.

Abstract

Background: The ALS diagnostic challenges necessitate more robust diagnostic and prognostic methods. A potential biomarker in this regard is the alterations of ferritin levels in the serum and CSF of patients compared to controls.

Methods: The CSF and serum ferritin levels were measured in 50 ALS cases and 50 control patients with predefined exclusion criteria. The ELISA method was utilized for laboratory measurement and was statistically analyzed using the SPSS.

Results: Heightened serum ferritin levels in cases were not statistically significant. However, CSF ferritin levels were significantly higher in ALS patients ( < 0.001). Serum ferritin levels were significantly negatively correlated with the disease duration ( = 0.015) and were significantly positively correlated with the disease progression rate (DPR) ( = 0.012).

Conclusion: Heightened CSF ferritin levels can be used for the diagnosis of ALS. The correlation between the serum ferritin levels with the DPR and its correlation with the disease duration suggests potential prognostic utilities.

Citing Articles

Associations of Vitamin D With GPX4 and Iron Parameters in Chronic Obstructive Pulmonary Disease Patients: A Case-Control Study.

Fei J, Liu L, Li J, Zhou Q, Wei Y, Zhou T Can Respir J. 2024; 2024:4505905.

PMID: 39502871 PMC: 11535414. DOI: 10.1155/2024/4505905.

Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.

Samuel Olajide T, Oyerinde T, Omotosho O, Okeowo O, Olajide O, Ijomone O Neuroprotection. 2024; 2(3):182-195.

PMID: 39364217 PMC: 11449118. DOI: 10.1002/nep3.56.

Iron homeostasis and post-hemorrhagic hydrocephalus: a review.

Pan S, Hale A, Lemieux M, Raval D, Garton T, Sadler B Front Neurol. 2024; 14:1287559.

PMID: 38283681 PMC: 10811254. DOI: 10.3389/fneur.2023.1287559.

Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients.

Gonzalez-Mingot C, Miana-Mena F, Inarrea P, Iniguez C, Capablo J, Osta R J Clin Med. 2023; 12(10).

PMID: 37240666 PMC: 10219422. DOI: 10.3390/jcm12103560.

Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.

Sanchez-Tejerina D, Llaurado A, Sotoca J, Lopez-Diego V, Vidal Taboada J, Salvado M Cells. 2023; 12(8).

PMID: 37190090 PMC: 10136823. DOI: 10.3390/cells12081180.

References

Hadzhieva M, Kirches E, Mawrin C . Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol Appl Neurobiol. 2013; 40(3):240-57. DOI: 10.1111/nan.12096. View

Qureshi M, Brown Jr R, Rogers J, Cudkowicz M . Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol J. 2009; 2:51-4. PMC: 2627516. DOI: 10.2174/1874205X00802010051. View

Logroscino G, Piccininni M . Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference. Neuroepidemiology. 2019; 52(1-2):93-103. DOI: 10.1159/000493386. View

Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R . Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology. 2020; 95(1):e59-e69. PMC: 7371380. DOI: 10.1212/WNL.0000000000009559. View

Sun Q, Yang F, Wang H, Cui F, Li Y, Li S . Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study. Amyotroph Lateral Scler Frontotemporal Degener. 2019; 20(3-4):186-191. DOI: 10.1080/21678421.2018.1555599. View

Zheng Y, Gao L, Wang D, Zang D . Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2016; 136(2):145-150. DOI: 10.1111/ane.12708. View

Petillon C, Hergesheimer R, Puy H, Corcia P, Vourch P, Andres C . The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls. Front Neurosci. 2019; 12:1031. PMC: 6341213. DOI: 10.3389/fnins.2018.01031. View

Verber N, Shaw P . Biomarkers in amyotrophic lateral sclerosis: a review of new developments. Curr Opin Neurol. 2020; 33(5):662-668. DOI: 10.1097/WCO.0000000000000854. View

Patin F, Corcia P, Madji Hounoum B, Veyrat-Durebex C, Respaud E, Piver E . Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis. Eur J Neurol. 2015; 22(10):1385-90. DOI: 10.1111/ene.12754. View

10.

Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y . Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012; 51(12):1501-8. DOI: 10.2169/internalmedicine.51.7465. View

11.

Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V . Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One. 2012; 7(9):e45034. PMC: 3443244. DOI: 10.1371/journal.pone.0045034. View

12.

Chen P, Miah M, Aschner M . Metals and Neurodegeneration. F1000Res. 2016; 5. PMC: 4798150. DOI: 10.12688/f1000research.7431.1. View

13.

Barber S, Shaw P . Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2009; 48(5):629-41. DOI: 10.1016/j.freeradbiomed.2009.11.018. View

14.

Cheng Y, Chen Y, Shang H . Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Transl Neurodegener. 2021; 10(1):3. PMC: 7792103. DOI: 10.1186/s40035-020-00228-9. View

15.

Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K . Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011; 303(1-2):95-9. DOI: 10.1016/j.jns.2011.01.003. View

16.

Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, Wallesch M, Schoenfeld P . Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience. 2012; 230:94-101. DOI: 10.1016/j.neuroscience.2012.11.021. View

17.

Hu X, Yang Y, Su J, Yao C . Meta-analysis of the relationship between amyotrophic lateral sclerosis and susceptibility to serum ferritin level elevation. Neurosciences (Riyadh). 2016; 21(2):120-5. PMC: 5107265. DOI: 10.17712/nsj.2016.2.20150482. View

18.

Su X, Clardy S, Stephens H, Simmons Z, Connor J . Serum ferritin is elevated in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 16(1-2):102-7. DOI: 10.3109/21678421.2014.984723. View

19.

Yu J, Wang N, Qi F, Wang X, Zhu Q, Lu Y . Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis. Biomed Rep. 2018; 9(4):333-338. PMC: 6142032. DOI: 10.3892/br.2018.1138. View